References
- Andersson M., Müntzing J. The effect of a long-acting estrogen on the activity and distribution of some hydrolases in the ventral prostate of intact, castrated and androgen-treated castrated adult rats. Invest Urol 1972; 9: 401
- Jönsson G., Högberg B. Treatment of advanced prostatic carcinoma with Estracyt. A preliminary report. Scand J Urol Nephrol 1971; 5: 103
- Lindberg B. Treatment of rapidly progressing prostatic carcinoma with Estracyt. J Urol 1972; 108: 303
- Müntzing J., Nilsson T. Enzyme activity and distribution in the hyperplastic and cancerous human prostate. Scand J Urol Nephrol 1972; 6: 107
- Müntzing J., Shukla S. K., Chu M. C., Mittelman A., Murphy G. P. Pharmacoclinical studies on oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate. Invest Urol 1974; 12: 65
- Nilsson T., Müntzing J. Estracyt in advanced prostatic carcinoma. Case report. Scand J Urol Nephrol 1972; 6: 11
- Nilsson T., Müntzing J. Histochemical and biochemical enzyme studies in prostatic carcinomatous tissue before and during treatment with estrogen. Scand J Urol Nephrol 1973a; 7: 14
- Nilsson T., Müntzing J. Histochemical and biochemical investigation of advanced prostatic carcinoma treated with estramustine phosphate, Estracyt. Scand J Urol Nephrol 1973b; 7: 18
- Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bull 1945; 1: 80